Citation Impact
Citing Papers
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
2012
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
2012
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Complex interplay between -catenin signalling and Notch effectors in intestinal tumorigenesis
2011 StandoutNobel
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
2010
Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma
2017
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
2020
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Tumor-exosomes and leukocyte activation: an ambivalent crosstalk
2012
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
2014
Atonal Homolog 1 Is Required for Growth and Differentiation Effects of Notch/γ-Secretase Inhibitors on Normal and Cancerous Intestinal Epithelial Cells
2010
Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling
2009
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
The mechanisms of Hedgehog signalling and its roles in development and disease
2013 Standout
Notch signalling in solid tumours: a little bit of everything but not all the time
2011
Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
2014
Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments
2011
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use
2003
Regulatory T Cells in Cancer
2010
The biology and function of fibroblasts in cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hepatocellular carcinoma
2021 Standout
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
2021
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
2010
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
2018
Gut microbiome and health: mechanistic insights
2022 Standout
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
2018
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
Combinations of Bevacizumab With Cancer Immunotherapy
2018
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
2011
Targeting regulatory T cells
2012
Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity
2012
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
2012
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
2011
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Hedgehog beyond medulloblastoma and basal cell carcinoma
2010
Tumor microenvironment is multifaceted
2011
Targeting autophagy in cancer
2017 Standout
Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment
2021
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
2011
Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
2010
The secret ally: immunostimulation by anticancer drugs
2012
Cancer-related inflammation and treatment effectiveness
2014 Standout
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
2018
Pan-cancer deconvolution of tumour composition using DNA methylation
2018
Notch: Architect, Landscaper, and Guardian of the Intestine
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
The primary cilium: a signalling centre during vertebrate development
2010 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Cancer immunology—analysis of host and tumor factors for personalized medicine
2011
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
The Intersection between Tumor Angiogenesis and Immune Suppression
2019
Regulatory T Cells and Human Disease
2020 StandoutNobel
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Hepatocyte‐derived exosomes promote T follicular regulatory cell expansion during hepatitis C virus infection
2017
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
2017 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Regulation of the anti-tumour immune response by cancer-associated fibroblasts
2014
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Modulation of Immunity by Antiangiogenic Molecules in Cancer
2012
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Junji Wada being referenced
Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway
2009
Crosstalk of hedgehog and Wnt pathways in gastric cancer
2008
A LARGE QUANTITY OF CD3−/CD19−/CD16−LYMPHOCYTES IN MALIGNANT PLEURAL EFFUSION FROM A PATIENT WITH RECURRENT CHOLANGIO CELL CARCINOMA
2002
VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
2009
γ-Secretase Inhibitors Enhance Taxane-Induced Mitotic Arrest and Apoptosis in Colon Cancer Cells
2007
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
2009
Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions.
2010
Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells.
2009
The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions.
2009